Table 3.
Characteristics | Studies | nVC | Total patients | Any VC | Total patients | P‐value |
---|---|---|---|---|---|---|
Recipient age, mean (SD) | 61,22,23,25,26,27 | 42.0 (12.4) | 2529 | 54.3 (10.8) | 721 | <0.001* |
Male sex, n (%) | 51,22,23,26,27 | 977 (63.9) | 1528 | 421 (64.6) | 652 | 0.779 |
Smoking, n (%) | 222,23 | 99 (19.5) | 508 | 59 (19.5) | 302 | <0.986 |
Hypertension, n (%) | 41,22,23,27 | 1106 (75.8) | 1459 | 518 (86.0) | 602 | <0.001* |
DM, n (%) | 51,22,23,26,27 | 160 (10.5) | 1528 | 211 (32.4) | 652 | <0.001* |
Hypercholesterolemia, n (%) | 31,23,27 | 387 (27.9) | 1385 | 251 (44.3) | 567 | <0.001* |
Pre‐emptive KTx, n (%) | 51,22,23,25,26 | 176 (7.3) | 2422 | 113 (16.3) | 694 | <0.001* |
Living donor, n (%) | 31,22,25 | 41 (2.1) | 1919 | 20 (5.3) | 377 | <0.001* |
History MI, n (%) | 222,23 | 34 (6.7) | 508 | 43 (14.2) | 302 | <0.001* |
History CVA/TIA, n (%) | 222,23 | 28 (5.5) | 508 | 27 (8.9) | 302 | 0.061 |
CVA, cerebrovascular accident; DM, diabetes mellitus; KTx, kidney transplantation; MI, myocardial infarction; nVC, no vascular calcification; SD, standard deviation; TIA, transient ischemic attack; VC, vascular calcification.